Search results: Sage Journals

Open accessReview articleFirst published 2022

The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma

Omar Albanyan, Julio Chavez, Javier Munoz

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2013

Clinical Characteristics and Risk of Relapse for Patients with Stage I-II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy

S. Mercadal, F. Climent, E. Domingo-Doménech [...]

Blood & Plasma

Open accessResearch articleFirst published 2024

Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects

Jingyi Li, Juan Mu, Jia Wang [...]

Cell Transplantation

Open accessCase reportFirst published 2019

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia

Priyavadhana Balasubramanian, Prashant Ramteke, Saumyaranjan Mallick [...]

Blood & Plasma

Open accessReview articleFirst published 2025

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review

Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti [...]

Technology in Cancer Research & Treatment

Restricted accessResearch articleFirst published August, 2026

Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)

Baptiste Fulbert, Théo Vincent, Justine Clarenne [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Restricted accessReview articleFirst published December, 2022

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published 2021

The use of tafasitamab in diffuse large B-cell lymphoma

Johannes Düll, Max Topp, Gilles Salles

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2018

The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma,Not Otherwise Specified

Jacqueline N Poston, Russell Dorer, David M Aboulafia

Blood & Plasma

Open accessReview articleFirst published 2022

The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma

Omar Albanyan, Julio Chavez, Javier Munoz

Therapeutic Advances in Hematology

Open accessResearch articleFirst published 2013

Clinical Characteristics and Risk of Relapse for Patients with Stage I-II Diffuse Large B-cell Lymphoma Treated in First Line with Immunochemotherapy

S. Mercadal, F. Climent, E. Domingo-Doménech [...]

Blood & Plasma

Open accessResearch articleFirst published 2024

Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects

Jingyi Li, Juan Mu, Jia Wang [...]

Cell Transplantation

Open accessCase reportFirst published 2019

Diffuse Large B-Cell Lymphoma Relapsing in Leukaemic Phase Presenting as Acute Leukaemia

Priyavadhana Balasubramanian, Prashant Ramteke, Saumyaranjan Mallick [...]

Blood & Plasma

Open accessReview articleFirst published 2025

The Role of Radiotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Post-CAR-T Therapy: A Systematic Literature Review

Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti [...]

Technology in Cancer Research & Treatment

Restricted accessResearch articleFirst published August, 2026

Descriptive analysis of the efficacity of R-GEMOX /R-IE/R-CEPP in patients with relapsed/refractory (R/R) transplant-ineligible diffuse large B-cell lymphoma (DLBCL)

Baptiste Fulbert, Théo Vincent, Justine Clarenne [...]

Journal of Oncology Pharmacy Practice

Open accessResearch articleFirst published 2025

Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs

Jiangtao Li, Wenxuan Huo, Yang Yang [...]

Cell Transplantation

Restricted accessReview articleFirst published December, 2022

New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma

Donald C. Moore, Matthew R. Peery, Katherine A. Tobon [...]

Journal of Oncology Pharmacy Practice

Open accessReview articleFirst published 2021

The use of tafasitamab in diffuse large B-cell lymphoma

Johannes Düll, Max Topp, Gilles Salles

Therapeutic Advances in Hematology

Open accessCase reportFirst published 2018

The Diving Bell and the Butterfly Revisited: A Fatal Case of Locked-in Syndrome in a Man With Epstein-Barr Virus–Positive Diffuse Large B-Cell Lymphoma,Not Otherwise Specified

Jacqueline N Poston, Russell Dorer, David M Aboulafia

Blood & Plasma